Blood Transfusion Diagnostics Market segment
The Blood Transfusion Diagnostics Market can be divided into major segments: infectious disease screening, blood grouping, compatibility testing, and nucleic acid testing. Infectious disease testing remains dominant because ensuring pathogen-free transfusions is the foremost priority.
Compatibility and blood grouping tests are essential in preventing adverse reactions, while NAT is the fastest-growing segment due to its high sensitivity. Hospitals dominate as the main end-users, though blood banks are steadily increasing their role in providing safe transfusion diagnostics.
Discussion participants can analyze which segment holds the highest potential. Should investment prioritize cutting-edge NAT, or should focus remain on strengthening routine testing in resource-limited settings?
